A new CD21 low B cell population in the peripheral blood of patients with SLE

Clinical Immunology

Volumn 113, Issue 2, 2004, Pages 161-171

  Wehr, Claudia ^a   Eibel, Hermann ^b   Masilamani, Madhan ^c   Illges, Harald ^c,d   Schlesier, Michael ^a   Peter, Hans Hartmut ^a   Warnatz, Klaus ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Clin Research Unit for Rheumatology   (Germany)

^c UNIVERSITY OF KONSTANZ   (Germany)

^d UNIVERSITY OF KONSTANZ   (Switzerland)

Author keywords

B cell; CD21; Homeostasis; Memory B cells; Plasmablasts; Systemic lupus erythematosus; Transitional B cells

Indexed keywords

CD19 ANTIGEN; CD24 ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; CD86 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; LEUKOCYTE ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HOMEOSTASIS; HUMAN; MALE; MEMORY CELL; PHENOTYPE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MIDDLE AGED;

ADULT; ANTIGENS, CD; AUTOIMMUNE DISEASES; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RECEPTORS, COMPLEMENT 3D;

EID: 4644293557     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2004.05.010     Document Type: Article

References (48)

1. E.K. Wakeland, K. Liu, R.R. Graham, and T.W. Behrens Delineating the genetic basis of systemic lupus erythematosus Immunity 15 2001 397 408
2. M.C. Pickering, M. Botto, P.R. Taylor, P.J. Lachmann, and M.J. Walport Systemic lupus erythematosus, complement deficiency, and apoptosis Adv. Immunol. 76 2000 227 324
3. I. Baumann, W. Kolowos, R.E. Voll, B. Manger, U. Gaipl, W.L. Neuhuber, T. Kirchner, J.R. Kalden, and M. Herrmann Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus Arthritis Rheum. 46 2002 191 201
4. G.C. Tsokos, H.K. Wong, E.J. Enyedy, and M.P. Nambiar Immune cell signaling in lupus Curr. Opin. Rheumatol. 12 2000 355 363
5. G.M. Kammer, A. Perl, B.C. Richardson, and G.C. Tsokos Abnormal T cell signal transduction in systemic lupus erythematosus Arthritis Rheum. 46 2002 1139 1154
6. S.N. Liossis, B. Kovacs, G. Dennis, G.M. Kammer, and G.C. Tsokos B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events J. Clin. Invest. 98 1996 2549 2557
7. L. Llorente, W. Zou, Y. Levy, Y. Richaud-Patin, J. Wijdenes, J. Alcocer-Varela, B. Morel-Fourrier, J.C. Brouet, D. Alarcon-Segovia, and P. Galanaud Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus J. Exp. Med. 181 1995 839 844
8. M. Bijl, G. Horst, P.C. Limburg, and C.G. Kallenberg Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus Ann. Rheum. Dis. 60 2001 523 526
9. J.G. Wilson, W.D. Ratnoff, P.H. Schur, and D.T. Fearon Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus Arthritis Rheum. 29 1986 739 747
10. H.V. Marquart, A. Svendsen, J.M. Rasmussen, C.H. Nielsen, P. Junker, S.E. Svehag, and R.G. Leslie Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE) Clin. Exp. Immunol. 101 1995 60 65
11. A. Desai-Mehta, L. Lu, R. Ramsey-Goldman, and S.K. Datta Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production J. Clin. Invest. 97 1996 2063 2073
12. C. Mohan, L. Morel, P. Yang, and E.K. Wakeland Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity J. Immunol. 159 1997 454 465
13. Y. Harada, M.M. Kawano, N. Huang, M.S. Mahmoud, I.A. Lisukov, K. Mihara, T. Tsujimoto, and A. Kuramoto Identification of early plasma cells in peripheral blood and their clinical significance Br. J. Haematol. 92 1996 184 191
14. M. Odendahl, A. Jacobi, A. Hansen, E. Feist, F. Hiepe, G.R. Burmester, P.E. Lipsky, A. Radbruch, and T. Dorner Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus J. Immunol. 165 2000 5970 5979
15. E. Arce, D.G. Jackson, M.A. Gill, L.B. Bennett, J. Banchereau, and V. Pascual Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus J. Immunol. 167 2001 2361 2369
16. S. Koarada, Y. Tada, O. Ushiyama, F. Morito, N. Suzuki, A. Ohta, K. Miyake, M. Kimoto, and K. Nagasawa B cells lacking RP105, a novel B cell antigen, in systemic lupus erythematosus Arthritis Rheum. 42 1999 2593 2600
17. K. Iida, R. Mornaghi, and V. Nussenzweig Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus J. Exp. Med. 155 1982 1427 1438
18. S.A. Boackle, V.M. Holers, X. Chen, G. Szakonyi, D.R. Karp, E.K. Wakeland, and L. Morel Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein Immunity 15 2001 775 785
19. E.M. Tan, A.S. Cohen, J.F. Fries, A.T. Masi, D.J. McShane, N.F. Rothfield, J.G. Schaller, N. Talal, and R.J. Winchester The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum. 25 1982 1271 1277
20. M. Mosca, W. Bencivelli, C. Vitali, P. Carrai, R. Neri, and S. Bombardieri The validity of the ECLAM index for the retrospective evaluation of disease activity in systemic lupus erythematosus Lupus 9 2000 445 450
21. E. Rother, B. Lang, R. Coldewey, K. Hartung, and H.H. Peter Complement split product C3d as an indicator of disease activity in systemic lupus erythematosus Clin. Rheumatol. 12 1993 31 35
22. M. Masilamani, J. Von Kempis, and H. Illges Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis Rheumatology (Oxford) 43 2004 186 190
23. M. Masilamani, H.J. Apell, and H. Illges Purification and characterization of soluble CD21 from human plasma by affinity chromatography and density gradient centrifugation J. Immunol. Methods 270 2002 11 18
24. U. Klein, K. Rajewsky, and R. Kuppers Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells J. Exp. Med. 188 1998 1679 1689
25. K. Agematsu, S. Hokibara, H. Nagumo, K. Shinozaki, S. Yamada, and A. Komiyama Plasma cell generation from B-lymphocytes via CD27/CD70 interaction Leuk. Lymphoma 35 1999 219 225
26. N.L. Bernasconi, E. Traggiai, and A. Lanzavecchia Maintenance of serological memory by polyclonal activation of human memory B cells Science 298 2002 2199 2202
27. C. Groth, R. Drager, K. Warnatz, G. Wolff-Vorbeck, S. Schmidt, H. Eibel, M. Schlesier, and H.H. Peter Impaired up-regulation of CD70 and CD86 in naive (CD27-) B cells from patients with common variable immunodeficiency (CVID) Clin. Exp. Immunol. 129 2002 133 139
28. R. Forster, T. Emrich, E. Kremmer, and M. Lipp Expression of the G-protein-coupled receptor BLR1 defines mature, recirculating B cells and a subset of T-helper memory cells Blood 84 1994 830 840
29. C.H. Kim, E.J. Kunkel, J. Boisvert, B. Johnston, J.J. Campbell, M.C. Genovese, H.B. Greenberg, and E.C. Butcher Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential J. Clin. Invest. 107 2001 595 601
30. T.F. Tedder, M. Inaoki, and S. Sato The CD19â€"CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity Immunity 6 1997 107 118
31. P. Engel, L.J. Zhou, D.C. Ord, S. Sato, B. Koller, and T.F. Tedder Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule Immunity 3 1995 39 50
32. S. Sato, M. Hasegawa, M. Fujimoto, T.F. Tedder, and K. Takehara Quantitative genetic variation in CD19 expression correlates with autoimmunity J. Immunol. 165 2000 6635 6643
33. K. Warnatz, A. Denz, R. Drager, M. Braun, C. Groth, G. Wolff-Vorbeck, H. Eibel, M. Schlesier, and H.H. Peter Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease Blood 99 2002 1544 1551
34. M. Hasegawa, M. Fujimoto, J.C. Poe, D.A. Steeber, and T.F. Tedder CD19 can regulate B lymphocyte signal transduction independent of complement activation J. Immunol. 167 2001 3190 3200
35. V. Fremeaux-Bacchi, J.P. Aubry, J.Y. Bonnefoy, M.D. Kazatchkine, J.P. Kolb, and E.M. Fischer Soluble CD21 induces activation and differentiation of human monocytes through binding to membrane CD23 Eur. J. Immunol. 28 1998 4268 4274
36. G. Muller, and M. Lipp Shaping up adaptive immunity: the impact of CCR7 and CXCR5 on lymphocyte trafficking Microcirculation 10 2003 325 334
37. G. Muller, U.E. Hopken, and M. Lipp The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity Immunol. Rev. 195 2003 117 135
38. T. Okada, V.N. Ngo, E.H. Ekland, R. Forster, M. Lipp, D.R. Littman, and J.G. Cyster Chemokine requirements for B cell entry to lymph nodes and Peyer's patches J. Exp. Med. 196 2002 65 75
39. S. Weller, A. Faili, C. Garcia, M.C. Braun, F. Le Deist, G. Saint Basile, O. Hermine, A. Fischer, C.A. Reynaud, and J.C. Weill CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans Proc. Natl. Acad. Sci. U. S. A. 98 2001 1166 1170
40. S. Weller, A. Faili, S. Aoufouchi, Q. Gueranger, M. Braun, C.A. Reynaud, and J.C. Weill Hypermutation in human B cells in vivo and in vitro Ann. N. Y. Acad. Sci. 987 2003 158 165
41. S. Kruetzmann, M.M. Rosado, H. Weber, U. Germing, O. Tournilhac, H.H. Peter, R. Berner, A. Peters, T. Boehm, A. Plebani, I. Quinti, and R. Carsetti Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen J. Exp. Med. 197 2003 939 945
42. F. Liote, J. Angle, N. Gilmore, and C.K. Osterland Asplenism and systemic lupus erythematosus Clin. Rheumatol. 14 1995 220 223
43. J.O. Bohnhorst, M.B. Bjorgan, J.E. Thoen, J.B. Natvig, and K.M. Thompson Bm1â€"Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjogren's syndrome J. Immunol. 167 2001 3610 3618
44. R. Carsetti, M.M. Rosado, and H. Wardmann Peripheral development of B cells in mouse and man Immunol. Rev. 197 2004 179 191
45. G. Janossy, M. Bofill, and H.J. Schuurman Human B-lymphoid differentiation: normal versus malignant Neth. J. Med. 39 1991 232 243
46. D.S. Weinberg, K.A. Ault, M. Gurley, and G.S. Pinkus The human lymph node germinal center cell: characterization and isolation by using two-color flow cytometry J. Immunol. 137 1986 1486 1494
47. F. Loder, B. Mutschler, R.J. Ray, C.J. Paige, P. Sideras, R. Torres, M.C. Lamers, and R. Carsetti B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals J. Exp. Med. 190 1999 75 89
48. L.D. Erickson, L.L. Lin, B. Duan, L. Morel, and R.J. Noelle A genetic lesion that arrests plasma cell homing to the bone marrow Proc. Natl. Acad. Sci. U. S. A. 100 2003 12905 12910